Rao SX - Search Results

1

Diagnostic performance of gadoxetic acid-enhanced abbreviated magnetic resonance imaging protocol in small hepatocellular carcinoma (≤2 cm) in high-risk patients.

Wang JH, Qiu QS, Dong SY, Chen XS, Wang WT, Yang YT, Sun W, Rao SX. Wang JH, et al. Among authors: rao sx. Acta Radiol. 2023 Oct;64(10):2687-2696. doi: 10.1177/02841851231195567. Epub 2023 Sep 10. Acta Radiol. 2023. PMID: 37691270

2

Impact of slice thickness on semi-automated measurements for volume and whole-tumor attenuation of colorectal hepatic metastases in multislice computed tomography.

Rao SX, Meng T, Zhang LJ, Zeng MS. Rao SX, et al. Acta Radiol. 2013 Oct;54(8):863-8. doi: 10.1177/0284185113488579. Epub 2013 May 23. Acta Radiol. 2013. PMID: 23761557

3

Usefulness of two-point Dixon fat-water separation technique in gadoxetic acid-enhanced liver magnetic resonance imaging.

Ding Y, Rao SX, Chen CZ, Li RC, Zeng MS. Ding Y, et al. Among authors: rao sx. World J Gastroenterol. 2015 Apr 28;21(16):5017-22. doi: 10.3748/wjg.v21.i16.5017. World J Gastroenterol. 2015. PMID: 25945017 Free PMC article.

4

Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine.

Chen CZ, Rao SX, Ding Y, Zhang SJ, Li F, Gao Q, Zeng MS. Chen CZ, et al. Among authors: rao sx. Hepatol Int. 2014 Jan;8(1):104-11. doi: 10.1007/s12072-013-9467-7. Epub 2013 Aug 17. Hepatol Int. 2014. PMID: 26202411

5

Assessment of Microvascular Invasion of Hepatocellular Carcinoma with Diffusion Kurtosis Imaging.

Wang WT, Yang L, Yang ZX, Hu XX, Ding Y, Yan X, Fu CX, Grimm R, Zeng MS, Rao SX. Wang WT, et al. Among authors: rao sx. Radiology. 2018 Feb;286(2):571-580. doi: 10.1148/radiol.2017170515. Epub 2017 Sep 22. Radiology. 2018. PMID: 28937853

6

Staging liver fibrosis with DWI: is there an added value for diffusion kurtosis imaging?

Yang L, Rao S, Wang W, Chen C, Ding Y, Yang C, Grimm R, Yan X, Fu C, Zeng M. Yang L, et al. Eur Radiol. 2018 Jul;28(7):3041-3049. doi: 10.1007/s00330-017-5245-6. Epub 2018 Jan 30. Eur Radiol. 2018. PMID: 29383522

7

Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.

Ni T, Shang XS, Wang WT, Hu XX, Zeng MS, Rao SX. Ni T, et al. Among authors: rao sx. Br J Radiol. 2018 Jul;91(1088):20180017. doi: 10.1259/bjr.20180017. Epub 2018 Jun 5. Br J Radiol. 2018. PMID: 29791202 Free PMC article.

8

T₁ mapping on gadoxetic acid-enhanced MR imaging predicts recurrence of hepatocellular carcinoma after hepatectomy.

Wang WT, Zhu S, Ding Y, Yang L, Chen CZ, Ye QH, Ji Y, Zeng MS, Rao SX. Wang WT, et al. Among authors: rao sx. Eur J Radiol. 2018 Jun;103:25-31. doi: 10.1016/j.ejrad.2018.03.027. Epub 2018 Mar 28. Eur J Radiol. 2018. PMID: 29803381

9

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017).

Ding Y, Rao SX, Wang WT, Chen CZ, Li RC, Zeng M. Ding Y, et al. Among authors: rao sx. Cancer Imaging. 2018 Dec 7;18(1):48. doi: 10.1186/s40644-018-0183-3. Cancer Imaging. 2018. PMID: 30526674 Free PMC article.

10

MR features based on LI-RADS identify cytokeratin 19 status of hepatocellular carcinomas.

Hu XX, Wang WT, Yang L, Yang ZX, Liang HY, Ding Y, Ji Y, Zeng MS, Rao SX. Hu XX, et al. Among authors: rao sx. Eur J Radiol. 2019 Apr;113:7-14. doi: 10.1016/j.ejrad.2019.01.036. Epub 2019 Jan 31. Eur J Radiol. 2019. PMID: 30927962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters